Global Health Ltd approved Q4 FY26 results with standalone net profit of ₹1.24B and revenue of ₹9.61B.
Board recommended final dividend of ₹0.50 per share (25%) for FY26, subject to shareholder approval.
Appointed Kedar Apte as Chief Marketing Officer and Jagdeep Singh as General Counsel effective May 14, 2026.
Noted resignation of Richa Singh as Senior Management Personnel effective May 20, 2026.